Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis
Clinical trial NCT03926026 · COMPLETED
Trial details
- NCT number
- NCT03926026
- Sponsor
- Nicox Ophthalmics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-18
- Primary completion
- 2019-10-21
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.